Schedule 13G ownership disclosure

REGULUS THERAPEUTICS INC

Security class unavailable · CUSIP: 75915K200

Event date: 2022-04-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
29,048,265
Percent of class
19.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-22-000625
Form type
SC 13G
Filer
FEDERATED HERMES, INC.
CIK
CIK 1056288
Filed
May 16, 2022
Reporting period
Apr 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub